EVO Company Profile and Key Details

Q: Who are the executives of EVO?

Mr. Enno SpillnerChief Financial Officer & Member of Management BoardDr. Ian M. HunneyballSenior Vice President of Programme Management & Clinical OperationsDr. Matthias EversChief Bus. Officer & Member of Management BoardMs. Monika ConradtGlobal Head of HRDr. Craig JohnstoneChief Operating Officer & Member of Management BoardDr. Werner Lanthaler M.B.A., MBA, MPA, Ph.D.Chairman of Management Board & Chief Executive OfficerDr. Cord Dohrmann Ph.D.Chief Scientific Officer & Member of Management BoardDr. Craig Johnstone Ph.D.Chief Operating Officer & Member of Management BoardDr. Matthias Evers Ph.D.Chief Bus. Officer & Member of Management BoardMs. Anja BoslerPrincipal Accounting Officer and Senior Vice President of Group AccountingMr. Volker BraunSenior Vice President and Global Head of Investor Relations & ESGDr. Christian DargelEVice President Global Head of Legal & ComplianceGabriele HansenSenior Vice President & Head of Global Corporation Communications & MarketingMs. Laetitia RouxelChief Financial Officer & Member of Management Board

NASDAQ : EVO

Evotec SE

$1.81

-0.01-0.55%

At Close 4:00 PM

70.41

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Evotec SE (EVO) stock declined over -0.55%, trading at $1.81 on NASDAQ, down from the previous close of $1.82. The stock opened at $1.82, fluctuating between $1.81 and $1.82 in the recent session.

Stock Snapshot

1.82

Prev. Close

642.98M

Market Cap

1.805

Day Low

-2.56

P/E Ratio

-0.70813

EPS (TTM)

-1.09

Cash Flow per Share

1.82

Open

355.24M

Number of Shares

1.82

Day High

98.74%

Free Float in %

6.45

Book Value

43.75K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 09, 2026	1.83	1.83	1.81	1.81	43.75K
Sep 08, 2026	1.83	1.83	1.80	1.82	64.21K
Sep 04, 2026	1.86	1.86	1.84	1.86	121.91K
Sep 03, 2026	1.95	1.95	1.89	1.90	94.28K
Sep 02, 2026	1.88	1.93	1.88	1.90	48.22K
Sep 01, 2026	1.85	1.86	1.80	1.80	38.4K
Aug 31, 2026	1.88	1.89	1.86	1.88	65.81K
Aug 28, 2026	1.95	1.95	1.91	1.91	28.2K
Aug 27, 2026	1.95	1.97	1.95	1.97	31.28K
Aug 26, 2026	1.95	1.96	1.93	1.95	31.08K
Aug 25, 2026	1.88	1.90	1.87	1.89	25.28K
Aug 24, 2026	1.92	1.92	1.89	1.89	22.64K
Aug 21, 2026	1.92	1.95	1.92	1.93	40.87K
Aug 20, 2026	1.95	1.96	1.92	1.96	79.22K
Aug 19, 2026	1.90	1.98	1.90	1.98	34.86K
Aug 18, 2026	1.93	1.94	1.89	1.91	18.15K
Aug 17, 2026	1.94	1.96	1.92	1.96	30.2K
Aug 14, 2026	1.97	1.98	1.94	1.96	41.96K
Aug 13, 2026	2.02	2.03	1.99	2.02	27.82K
Aug 12, 2026	2.11	2.20	2.09	2.19	49.39K

Contact Details

Hamburg, HA 22419

Germany

https://www.evotec.com 494 056 0810

About Company

Evotec SE operates globally as a dedicated partner, specializing in the discovery and advancement of new pharmaceutical products for the biotechnology and pharmaceutical sectors. Its comprehensive research and development initiatives encompass a broad spectrum of medical areas, such as metabolic disorders (including diabetes and its complications), fibrosis, infectious conditions, central nervous system (CNS) diseases, oncology, pain management, inflammatory ailments, immunological dysfunctions, rare diseases, respiratory conditions, and women's health. The company maintains strategic alliances and collaborations with numerous prominent organizations, including Bayer AG, Lilly, Chinook Therapeutics, Novo Nordisk A/S, Galapagos, Pfizer Inc., CONBA Pharmaceutical Co., Ltd., Bristol Myers Squibb Company, Zhejiang JingXin Pharmaceutical Co., Ltd, Kazia Therapeutics, Apeiron Biologics, and Takeda Pharmaceuticals. Established in 1993, the company was formerly known as Evotec AG, changing its name to Evotec SE in April 2019. Its corporate headquarters are located in Hamburg, Germany.

Stock Peers

ITCI

Intra-Cellular Therapies, Inc.$131.87 LNTH

0.26+0.26%

Lantheus Holdings, Inc.$100.70 ANIP

0.47+0.67%

ANI Pharmaceuticals, Inc.$70.70 ETON

-0.515-0.87%

Eton Pharmaceuticals, Inc.$58.83 ALKS

-0.09-0.20%

Alkermes plc$45.40 SUPN

-0.36-0.85%

Supernus Pharmaceuticals, Inc.$42.07 HROW

-0.3-0.79%

Harrow Health, Inc.$37.55 PAHC

-0.51-1.37%

Phibro Animal Health Corporation$36.80 INDV

0.45+1.31%

Indivior Pharmaceuticals Inc$34.77 PETQ

-0.01-0.03%

PetIQ, Inc.$30.98

Frequently Asked Questions

What is the current Evotec SE (EVO) stock price?

Evotec SE (NASDAQ: EVO) stock price is $1.81 in the last trading session. During the trading session, EVO stock reached the peak price of $1.82 while $1.81 was the lowest point it dropped to. The percentage change in EVO stock occurred in the recent session was -0.55% while the dollar amount for the price change in EVO stock was - $0.01.

EVO's industry and sector of operation?

The NASDAQ listed EVO is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Evotec SE designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of EVO?

Mr. Enno Spillner
Chief Financial Officer & Member of Management Board
Dr. Ian M. Hunneyball
Senior Vice President of Programme Management & Clinical Operations
Dr. Matthias Evers
Chief Bus. Officer & Member of Management Board
Ms. Monika Conradt
Global Head of HR
Dr. Craig Johnstone
Chief Operating Officer & Member of Management Board
Dr. Werner Lanthaler M.B.A., MBA, MPA, Ph.D.
Chairman of Management Board & Chief Executive Officer
Dr. Cord Dohrmann Ph.D.
Chief Scientific Officer & Member of Management Board
Dr. Craig Johnstone Ph.D.
Chief Operating Officer & Member of Management Board
Dr. Matthias Evers Ph.D.
Chief Bus. Officer & Member of Management Board
Ms. Anja Bosler
Principal Accounting Officer and Senior Vice President of Group Accounting
Mr. Volker Braun
Senior Vice President and Global Head of Investor Relations & ESG
Dr. Christian Dargel
EVice President Global Head of Legal & Compliance
Gabriele Hansen
Senior Vice President & Head of Global Corporation Communications & Marketing
Ms. Laetitia Rouxel
Chief Financial Officer & Member of Management Board

How EVO did perform over past 52-week?

EVO's closing price is 0.56% higher than its 52-week low of $1.80 where as its distance from 52-week high of $4.27 is -57.61%.

How many employees does EVO have?

Number of EVO employees currently stands at 4,553.

Link for EVO official website?

Official Website of EVO is: https://www.evotec.com

How do I contact EVO?

EVO could be contacted at phone 494 056 0810 and can also be accessed through its website. EVO operates from Essener Bogen 7, Hamburg, HA 22419, Germany.

How many shares of EVO are traded daily?

EVO stock volume for the day was 43.75K shares. The average number of EVO shares traded daily for last 3 months was 57.92K.

What is the market cap of EVO currently?

The market value of EVO currently stands at $642.98M with its latest stock price at $1.81 and 355.24M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	4553
Beta	1.26
Sales or Revenue	$781.43M
5Y Sales Change%	0.735%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

Employees	4553
Beta	1.26
Sales or Revenue	$781.43M
5Y Sales Change%	0.735%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic

EVO Company Profile and Key Details

Evotec SE

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Shareholding & Insider Activity

Technical Performance

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Company Overview

Valuation Metrics

Dividend & Fair Value

Price Forecast & Outlook

Key Takeaways